# Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

> **NCT06448208** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 11 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DIAGNOSTIC_TEST:** positron emission tomography (PET) scans

## Key facts

- **NCT ID:** NCT06448208
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-03
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06448208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06448208, "Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06448208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*